Treatment of substance abuse in patients with HIV infection. NLM AIDSLINE Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Treatment of substance abuse in patients with HIV infection.

Adv Alcohol Subst Abuse. 1987;7(2):143-57. Unique Identifier : AIDSLINE MED/88206989
Faltz BG; Madover S; University of California.

Abstract: The dual diagnosis of AIDS and substance abuse raises serious clinical and ethical issues for health care providers. Often, there are barriers to the diagnosis and referral for substance abuse treatment in people with HIV infection. Countertransference is one such barrier. Important educational needs of patients can be overlooked or not fully addressed. Essential information needs to be conveyed, regardless of whether or not a patient seeks substance abuse treatment. Early intervention and treatment are essential to minimize risk for HIV infection and transmission to others. Specific clinical issues that practitioners often address for patients with AIDS or ARC are appropriate interventions for denial of the HIV-related diagnosis coupled with the denial of substance abuse, difficulties in pain management, the difficulties of family and loved ones, the need for substance abuse relapse prevention, and the need for coordination of care among agencies.
Keywords: Acquired Immunodeficiency Syndrome/PREVENTION & CONTROL/ *TRANSMISSION Alcoholism/REHABILITATION Antibodies, Viral/ANALYSIS Attitude of Health Personnel Homosexuality Human HIV/IMMUNOLOGY Professional-Patient Relations Risk Factors Substance Abuse/*REHABILITATION JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/prevention&control/KWDtransmissionalcoholism/rehabilitationantibodies,viral/analysisattitudeofhealthpersonnelhomosexualityhumanhiv/immunologyprofessional-patientrelationsriskfactorssubstanceabuse/KWDrehabilitationjournalarticle
880830
M8880499

Copyright © 1988 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .